Barclays’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.86M Sell
31,988
-264,207
-89% -$14.3M ﹤0.01% 2394
2025
Q4
$13.7M Sell
296,195
-97,719
-25% -$4.37M 0.01% 1468
2025
Q3
$14.2M Sell
393,914
-44,495
-10% -$1.47M 0.01% 1421
2025
Q2
$14.3M Buy
438,409
+212,287
+94% +$6.96M 0.01% 1324
2025
Q1
$8.54M Sell
226,122
-28,763
-11% -$2.3M ﹤0.01% 1523
2024
Q4
$20.9M Buy
254,885
+45,132
+22% +$4.48M 0.01% 1100
2024
Q3
$24M Buy
209,753
+81,801
+64% +$7.37M 0.01% 975
2024
Q2
$9.66M Sell
127,952
-1,300
-1% -$88.5K ﹤0.01% 1213
2024
Q1
$8.83M Sell
129,252
-72,446
-36% -$5.02M ﹤0.01% 1484
2023
Q4
$12.7M Buy
201,698
+31,286
+18% +$1.62M 0.01% 1340
2023
Q3
$8.69M Buy
170,412
+68,904
+68% +$3.4M 0.01% 1051
2023
Q2
$5.07M Buy
101,508
+9,303
+10% +$441K ﹤0.01% 1336
2023
Q1
$3.46M Sell
92,205
-21,647
-19% -$918K ﹤0.01% 1794
2022
Q4
$5.46M Buy
113,852
+53,853
+90% +$2.11M ﹤0.01% 1555
2022
Q3
$1.44M Buy
59,999
+57,353
+2,168% +$1.45M ﹤0.01% 1963
2022
Q2
$58K Sell
2,646
-47,154
-95% -$1.09M ﹤0.01% 3981
2022
Q1
$1.2M Buy
+49,800
New +$1.09M ﹤0.01% 2262

Other funds holding PCVX